This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: C. R. Bard, Inc., Boston Scientific Scimed, Inc.. Active years: 2012-2014.
Company Filing History:
Years Active: 2012-2014
Title: Minoru Mashimo: Innovator in Electrophysiology
Introduction
Minoru Mashimo is a notable inventor based in Windham, NH (US). He has made significant contributions to the field of electrophysiology, particularly in the detection and mapping of atrial fibrillation. With a total of 3 patents to his name, his work has advanced the understanding and treatment of cardiac conditions.
Latest Patents
One of his latest patents is the "High density atrial fibrillation cycle length (AFCL) detection and mapping system." This system assists in locating the focus of atrial fibrillation by associating AFCL values and statistics with temporal locations on an electrogram. It also coordinates electrode locations with spectral analyses of electrogram signals, providing valuable information for ablation therapy.
Another significant patent is the "Rapid 3D mapping using multielectrode position data." This electrophysiology system allows for operator interaction with results, enabling rapid catheter positioning without the need for precise catheter location determinations. The map module coordinates EP data associated with each selected channel, updating the resulting map dynamically as changes occur.
Career Highlights
Throughout his career, Minoru Mashimo has worked with prominent companies in the medical device industry, including C. R. Bard, Inc. and Boston Scientific Scimed, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for electrophysiology.
Collaborations
Minoru has collaborated with notable professionals in his field, including David P. MacAdam and Pawel Kuklik. These collaborations have further enriched his work and contributed to advancements in cardiac care.
Conclusion
Minoru Mashimo's contributions to electrophysiology through his patents and collaborations highlight his role as an innovator in the medical field. His work continues to impact the treatment of atrial fibrillation and improve patient outcomes.